Search research articles
Contact Us
Filters
Showing results (41-50 of 193) with videos related to
Page
of 20
Sort By:
Clinical & Experimental Metastasis
|
April 23, 2015
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Lydia G M van der Geest, Jorine't Lam-Boer, Miriam Koopman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2012
Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer
Leonie J M Mekenkamp, Karin J Heesterbeek, Miriam Koopman, et al.
Pharmacoeconomics
|
May 10, 2013
Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence
Chantal W M van Gils, Saskia de Groot, William K Redekop, et al.
Journal of Gastrointestinal Cancer
|
May 24, 2022
Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases
Janine B Kastelijn, Leon M G Moons, Jakob W Kist, et al.
Therapeutic Advances in Gastroenterology
|
March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
JNCI Cancer Spectrum
|
July 31, 2019
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer
Jeroen W G Derksen, Sophie A Kurk, Marieke J Oskam, et al.
Therapeutic Advances in Gastroenterology
|
September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patients
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer
|
July 9, 2020
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data
Patricia A H Hamers, Marloes A G Elferink, Rebecca K Stellato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2023
Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis
Johannes J M Kwakman, Marinde J G Bond, Ramzi M Demichelis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review
Kaitlyn K H Goey, Jorine 't Lam-Boer, Johannes H W de Wilt, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 193) with videos related to
Sort By:
Page
of 20
Clinical & Experimental Metastasis
|
April 23, 2015
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Lydia G M van der Geest, Jorine't Lam-Boer, Miriam Koopman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2012
Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer
Leonie J M Mekenkamp, Karin J Heesterbeek, Miriam Koopman, et al.
Pharmacoeconomics
|
May 10, 2013
Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence
Chantal W M van Gils, Saskia de Groot, William K Redekop, et al.
Journal of Gastrointestinal Cancer
|
May 24, 2022
Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases
Janine B Kastelijn, Leon M G Moons, Jakob W Kist, et al.
Therapeutic Advances in Gastroenterology
|
March 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
JNCI Cancer Spectrum
|
July 31, 2019
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer
Jeroen W G Derksen, Sophie A Kurk, Marieke J Oskam, et al.
Therapeutic Advances in Gastroenterology
|
September 30, 2020
Model-based evaluation of the cost effectiveness of 3 <i>versus</i> 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patients
Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer
|
July 9, 2020
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data
Patricia A H Hamers, Marloes A G Elferink, Rebecca K Stellato, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 7, 2023
Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis
Johannes J M Kwakman, Marinde J G Bond, Ramzi M Demichelis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review
Kaitlyn K H Goey, Jorine 't Lam-Boer, Johannes H W de Wilt, et al.
Page
of 20